Contracts for accountable care organizations (ACOs) can be very different depending on who the payer is, according to Katherine Schneider, MD, MPhil, FAAFP, president and CEO of Delaware Valley ACO.
Contracts for accountable care organizations (ACOs) can be very different depending on who the payer is, according to Katherine Schneider, MD, MPhil, FAAFP, president and CEO of Delaware Valley ACO.
Transcript
What has been your experience with commercial contracts vs Medicare Shared Savings Program (MSSP)?
We are an ACO of about a quarter million lives and a third of our lives are in MSSP Track 1, about a third are in 3 private payer relationships, and a third are our own employees, actually, across our large joint venture health system enterprise. And, I think the biggest difference is the ability of us to have a face-to-face relationship and partner with the payers.
All of these contracts are different, we have the opportunity to negotiate, obviously, and that’s not just around favorable contract terms, around who gets more of a dollar, but it’s also understanding our local market and our ACO and our providers and being able to customize the programming and the clinical partnerships to where we are in our journey in care transformation. I think the biggest difference is that ability to partner with the payers locally.
How can ACOs participating in MSSP and commercial contracts, or just multiple commercial contracts, accommodate variability in these contracts?
The variability can be behind the scenes, in which case I don’t think it’s of huge concern or impact, but where it gets very complicated is where there’s variability at the point of care. So, things like quality metrics being all over the map or, worse yet, quality metrics that kind of overlap but not quite—different definitions, different specs, different ability to submit supplemental data, just as one example.
I think our job as an ACO is to protect our providers from that noise and chaos and allow them to focus on the care of the patient regardless of whose card they’re carrying in their pocket. The more that we can do that, we can’t always get everything perfectly and aligned and we know that, but the more that we can sort of keep that stuff in the background and allow our caregivers to just provide the highest level of care, great care experience, and bend the trend, obviously, is our goal.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More